Understanding dementia in people with Parkinson's disease
Official title: Investigations of Dementia in Parkinson Disease
Funded at Washington University · NIH-10612119 · Data updated 2026-11-12
This study is looking at how dementia affects people with Parkinson's disease over time, and it aims to find signs that can help predict memory and thinking problems, so we can create better treatments to slow down these changes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | September 23, 2021 |
| Project end | August 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $2,332,494 |
| NIH project number | 4RF1NS075321-12 |
| Project ID | NIH-10612119 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Parkinson's disease, particularly those experiencing cognitive decline.
✕Less likely to help
Patients with other forms of dementia not related to Parkinson's disease may not benefit from this research.
What this research studies
This research investigates the relationship between dementia and Parkinson's disease (PD), focusing on how cognitive decline occurs in patients over time. By examining biomarkers in cerebrospinal fluid and using advanced neuroimaging techniques, the study aims to identify changes that predict cognitive impairment in PD. Participants will be monitored through both cross-sectional and longitudinal assessments to gather comprehensive data on the progression of symptoms. The goal is to develop reliable indicators that can help in creating therapies to slow down the progression of PD-related dementia.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that slow the progression of dementia in Parkinson's disease patients.
How similar studies have gone: Previous research has shown promise in using biomarkers and neuroimaging to understand dementia in other conditions, suggesting potential success for this approach in Parkinson's disease.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Perlmutter, Joel Synes — Washington University
- Study coordinator: Perlmutter, Joel Synes
Related research
Other NIH-funded projects on the same topics.
-
Palmitoyltransferase and GBA1 function restoration in Parkinson’s and Lewy body dementia
A fast-moving study looks at whether tweaking a fat-attachment process on proteins can restore healthy enzyme function and slow the progression of Parkinson’s disease and Lewy body dementia.
-
Better palliative care for Black and Hispanic people with Parkinson's and Lewy body dementia
Designing culturally-tailored palliative care programs to better meet the needs of Black and Hispanic adults living with Parkinson's disease and Lewy body dementia.
-
Investigating brain connections related to dementia and walking problems in Parkinson's disease
This study is looking at how certain brain connections might affect memory and walking problems in people with Parkinson's disease, and it hopes to find clues that could help improve treatments for these challenges.
-
Improving palliative care for people with Parkinson's disease and related disorders in Black and Hispanic communities
This study is all about improving care for people with Parkinson's disease and Lewy Body Dementia, especially in Black and Hispanic communities, by understanding their specific needs and finding better ways to support them and their families.
-
Integrated palliative care for Parkinson’s disease and PD dementia: reducing low-value care and disparities
A study in people with Parkinson’s disease or Parkinson disease dementia tests how integrating palliative care can cut unnecessary hospitalizations and disparities.
-
Examining how integrated palliative care affects health outcomes in Parkinson's disease and Lewy body dementia.
This study is looking at how adding palliative care can help people with Parkinson's disease and Parkinson's disease dementia feel better by managing their symptoms and planning their care, so they can avoid unnecessary hospital visits and get the support they need.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.